| Literature DB >> 35539082 |
Weibing Xu1, Zhiyan Lin2, Guichen Li3, Haitao Long1, Mingyuan Du1, Guorui Fu1, Lumei Pu1.
Abstract
In this study, we report the preparation and characterization of the PVA-DTPA-Gd conjugate as a potential MRI contrast agent (CA). The r 1 value and the r 2/r 1 ratio were about 5.6 mM-1 s-1 and 1.31, respectively. In vitro toxicity studies not only demonstrated that the polymeric system possessed good biocompatibility, but also proved that the conjugate could be an attractive candidate for CA. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35539082 PMCID: PMC9075117 DOI: 10.1039/c9ra05607f
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Scheme 1The synthesis of the PVA–DTPA–Gd conjugate.
Fig. 1Cytotoxicity studies of PVA–DTPA–Gd in HUVEC cells after incubation for 48 h.
Fig. 2The hemolysis rate of PVA–DTPA–Gd.
Fig. 3(a) T1, (b) T2-relaxation rate and (c) T1-weighted MRI images of PVA–DTPA–Gd.